Our pathway PRS, including HLA-A, HLA-E, and HLA-DRA, reaffirms the importance of the HLA region, which is corroborated by previous studies in T1D [41], GD [42], and HT [43]. The gene discussed is HLA-DRA; the disease is hematocrit.